Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Circulating Tumor Cells (CTC) Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Ex-Vivo Positive Selection
1.2.3 In-Vivo Positive Selection
1.2.4 Negative Selection
1.2.5 Microchips & Single Spiral Micro Channel
1.3 Market by Application
1.3.1 Global Circulating Tumor Cells (CTC) Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Tumorigenesis Research
1.3.3 Emt Biomarkers Development
1.3.4 Cancer Stem Cell Research
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Circulating Tumor Cells (CTC) Market Perspective (2018-2033)
2.2 Circulating Tumor Cells (CTC) Growth Trends by Region
2.2.1 Global Circulating Tumor Cells (CTC) Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Circulating Tumor Cells (CTC) Historic Market Size by Region (2018-2023)
2.2.3 Circulating Tumor Cells (CTC) Forecasted Market Size by Region (2024-2033)
2.3 Circulating Tumor Cells (CTC) Market Dynamics
2.3.1 Circulating Tumor Cells (CTC) Industry Trends
2.3.2 Circulating Tumor Cells (CTC) Market Drivers
2.3.3 Circulating Tumor Cells (CTC) Market Challenges
2.3.4 Circulating Tumor Cells (CTC) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Circulating Tumor Cells (CTC) Players by Revenue
3.1.1 Global Top Circulating Tumor Cells (CTC) Players by Revenue (2018-2023)
3.1.2 Global Circulating Tumor Cells (CTC) Revenue Market Share by Players (2018-2023)
3.2 Global Circulating Tumor Cells (CTC) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Circulating Tumor Cells (CTC) Revenue
3.4 Global Circulating Tumor Cells (CTC) Market Concentration Ratio
3.4.1 Global Circulating Tumor Cells (CTC) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Circulating Tumor Cells (CTC) Revenue in 2022
3.5 Circulating Tumor Cells (CTC) Key Players Head office and Area Served
3.6 Key Players Circulating Tumor Cells (CTC) Product Solution and Service
3.7 Date of Enter into Circulating Tumor Cells (CTC) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Circulating Tumor Cells (CTC) Breakdown Data by Type
4.1 Global Circulating Tumor Cells (CTC) Historic Market Size by Type (2018-2023)
4.2 Global Circulating Tumor Cells (CTC) Forecasted Market Size by Type (2024-2033)
5 Circulating Tumor Cells (CTC) Breakdown Data by Application
5.1 Global Circulating Tumor Cells (CTC) Historic Market Size by Application (2018-2023)
5.2 Global Circulating Tumor Cells (CTC) Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Circulating Tumor Cells (CTC) Market Size (2018-2033)
6.2 North America Circulating Tumor Cells (CTC) Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Circulating Tumor Cells (CTC) Market Size by Country (2018-2023)
6.4 North America Circulating Tumor Cells (CTC) Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Circulating Tumor Cells (CTC) Market Size (2018-2033)
7.2 Europe Circulating Tumor Cells (CTC) Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Circulating Tumor Cells (CTC) Market Size by Country (2018-2023)
7.4 Europe Circulating Tumor Cells (CTC) Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Circulating Tumor Cells (CTC) Market Size (2018-2033)
8.2 Asia-Pacific Circulating Tumor Cells (CTC) Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Circulating Tumor Cells (CTC) Market Size by Region (2018-2023)
8.4 Asia-Pacific Circulating Tumor Cells (CTC) Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Circulating Tumor Cells (CTC) Market Size (2018-2033)
9.2 Latin America Circulating Tumor Cells (CTC) Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Circulating Tumor Cells (CTC) Market Size by Country (2018-2023)
9.4 Latin America Circulating Tumor Cells (CTC) Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Circulating Tumor Cells (CTC) Market Size (2018-2033)
10.2 Middle East & Africa Circulating Tumor Cells (CTC) Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Circulating Tumor Cells (CTC) Market Size by Country (2018-2023)
10.4 Middle East & Africa Circulating Tumor Cells (CTC) Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AdnaGen
11.1.1 AdnaGen Company Detail
11.1.2 AdnaGen Business Overview
11.1.3 AdnaGen Circulating Tumor Cells (CTC) Introduction
11.1.4 AdnaGen Revenue in Circulating Tumor Cells (CTC) Business (2018-2023)
11.1.5 AdnaGen Recent Development
11.2 Apocell
11.2.1 Apocell Company Detail
11.2.2 Apocell Business Overview
11.2.3 Apocell Circulating Tumor Cells (CTC) Introduction
11.2.4 Apocell Revenue in Circulating Tumor Cells (CTC) Business (2018-2023)
11.2.5 Apocell Recent Development
11.3 Biocep
11.3.1 Biocep Company Detail
11.3.2 Biocep Business Overview
11.3.3 Biocep Circulating Tumor Cells (CTC) Introduction
11.3.4 Biocep Revenue in Circulating Tumor Cells (CTC) Business (2018-2023)
11.3.5 Biocep Recent Development
11.4 Canopus Bioscience
11.4.1 Canopus Bioscience Company Detail
11.4.2 Canopus Bioscience Business Overview
11.4.3 Canopus Bioscience Circulating Tumor Cells (CTC) Introduction
11.4.4 Canopus Bioscience Revenue in Circulating Tumor Cells (CTC) Business (2018-2023)
11.4.5 Canopus Bioscience Recent Development
11.5 Creatv Microtech
11.5.1 Creatv Microtech Company Detail
11.5.2 Creatv Microtech Business Overview
11.5.3 Creatv Microtech Circulating Tumor Cells (CTC) Introduction
11.5.4 Creatv Microtech Revenue in Circulating Tumor Cells (CTC) Business (2018-2023)
11.5.5 Creatv Microtech Recent Development
11.6 Ikonisys
11.6.1 Ikonisys Company Detail
11.6.2 Ikonisys Business Overview
11.6.3 Ikonisys Circulating Tumor Cells (CTC) Introduction
11.6.4 Ikonisys Revenue in Circulating Tumor Cells (CTC) Business (2018-2023)
11.6.5 Ikonisys Recent Development
11.7 IV Diagnostics
11.7.1 IV Diagnostics Company Detail
11.7.2 IV Diagnostics Business Overview
11.7.3 IV Diagnostics Circulating Tumor Cells (CTC) Introduction
11.7.4 IV Diagnostics Revenue in Circulating Tumor Cells (CTC) Business (2018-2023)
11.7.5 IV Diagnostics Recent Development
11.8 Miltenyi Biotech
11.8.1 Miltenyi Biotech Company Detail
11.8.2 Miltenyi Biotech Business Overview
11.8.3 Miltenyi Biotech Circulating Tumor Cells (CTC) Introduction
11.8.4 Miltenyi Biotech Revenue in Circulating Tumor Cells (CTC) Business (2018-2023)
11.8.5 Miltenyi Biotech Recent Development
11.9 Nanostring Technologies
11.9.1 Nanostring Technologies Company Detail
11.9.2 Nanostring Technologies Business Overview
11.9.3 Nanostring Technologies Circulating Tumor Cells (CTC) Introduction
11.9.4 Nanostring Technologies Revenue in Circulating Tumor Cells (CTC) Business (2018-2023)
11.9.5 Nanostring Technologies Recent Development
11.10 Rarecells Diagnostics
11.10.1 Rarecells Diagnostics Company Detail
11.10.2 Rarecells Diagnostics Business Overview
11.10.3 Rarecells Diagnostics Circulating Tumor Cells (CTC) Introduction
11.10.4 Rarecells Diagnostics Revenue in Circulating Tumor Cells (CTC) Business (2018-2023)
11.10.5 Rarecells Diagnostics Recent Development
11.11 Vitatex
11.11.1 Vitatex Company Detail
11.11.2 Vitatex Business Overview
11.11.3 Vitatex Circulating Tumor Cells (CTC) Introduction
11.11.4 Vitatex Revenue in Circulating Tumor Cells (CTC) Business (2018-2023)
11.11.5 Vitatex Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Circulating Tumor Cells (CTC) Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Ex-Vivo Positive Selection
Table 3. Key Players of In-Vivo Positive Selection
Table 4. Key Players of Negative Selection
Table 5. Key Players of Microchips & Single Spiral Micro Channel
Table 6. Global Circulating Tumor Cells (CTC) Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Circulating Tumor Cells (CTC) Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Circulating Tumor Cells (CTC) Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Circulating Tumor Cells (CTC) Market Share by Region (2018-2023)
Table 10. Global Circulating Tumor Cells (CTC) Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Circulating Tumor Cells (CTC) Market Share by Region (2024-2033)
Table 12. Circulating Tumor Cells (CTC) Market Trends
Table 13. Circulating Tumor Cells (CTC) Market Drivers
Table 14. Circulating Tumor Cells (CTC) Market Challenges
Table 15. Circulating Tumor Cells (CTC) Market Restraints
Table 16. Global Circulating Tumor Cells (CTC) Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Circulating Tumor Cells (CTC) Market Share by Players (2018-2023)
Table 18. Global Top Circulating Tumor Cells (CTC) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Circulating Tumor Cells (CTC) as of 2022)
Table 19. Ranking of Global Top Circulating Tumor Cells (CTC) Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Circulating Tumor Cells (CTC) Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Circulating Tumor Cells (CTC) Product Solution and Service
Table 23. Date of Enter into Circulating Tumor Cells (CTC) Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Circulating Tumor Cells (CTC) Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Circulating Tumor Cells (CTC) Revenue Market Share by Type (2018-2023)
Table 27. Global Circulating Tumor Cells (CTC) Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Circulating Tumor Cells (CTC) Revenue Market Share by Type (2024-2033)
Table 29. Global Circulating Tumor Cells (CTC) Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Circulating Tumor Cells (CTC) Revenue Market Share by Application (2018-2023)
Table 31. Global Circulating Tumor Cells (CTC) Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Circulating Tumor Cells (CTC) Revenue Market Share by Application (2024-2033)
Table 33. North America Circulating Tumor Cells (CTC) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 34. North America Circulating Tumor Cells (CTC) Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Circulating Tumor Cells (CTC) Market Size by Country (2024-2033) & (US$ Million)
Table 36. Europe Circulating Tumor Cells (CTC) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. Europe Circulating Tumor Cells (CTC) Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Circulating Tumor Cells (CTC) Market Size by Country (2024-2033) & (US$ Million)
Table 39. Asia-Pacific Circulating Tumor Cells (CTC) Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 40. Asia-Pacific Circulating Tumor Cells (CTC) Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Circulating Tumor Cells (CTC) Market Size by Region (2024-2033) & (US$ Million)
Table 42. Latin America Circulating Tumor Cells (CTC) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Latin America Circulating Tumor Cells (CTC) Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Circulating Tumor Cells (CTC) Market Size by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa Circulating Tumor Cells (CTC) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Middle East & Africa Circulating Tumor Cells (CTC) Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Circulating Tumor Cells (CTC) Market Size by Country (2024-2033) & (US$ Million)
Table 48. AdnaGen Company Detail
Table 49. AdnaGen Business Overview
Table 50. AdnaGen Circulating Tumor Cells (CTC) Product
Table 51. AdnaGen Revenue in Circulating Tumor Cells (CTC) Business (2018-2023) & (US$ Million)
Table 52. AdnaGen Recent Development
Table 53. Apocell Company Detail
Table 54. Apocell Business Overview
Table 55. Apocell Circulating Tumor Cells (CTC) Product
Table 56. Apocell Revenue in Circulating Tumor Cells (CTC) Business (2018-2023) & (US$ Million)
Table 57. Apocell Recent Development
Table 58. Biocep Company Detail
Table 59. Biocep Business Overview
Table 60. Biocep Circulating Tumor Cells (CTC) Product
Table 61. Biocep Revenue in Circulating Tumor Cells (CTC) Business (2018-2023) & (US$ Million)
Table 62. Biocep Recent Development
Table 63. Canopus Bioscience Company Detail
Table 64. Canopus Bioscience Business Overview
Table 65. Canopus Bioscience Circulating Tumor Cells (CTC) Product
Table 66. Canopus Bioscience Revenue in Circulating Tumor Cells (CTC) Business (2018-2023) & (US$ Million)
Table 67. Canopus Bioscience Recent Development
Table 68. Creatv Microtech Company Detail
Table 69. Creatv Microtech Business Overview
Table 70. Creatv Microtech Circulating Tumor Cells (CTC) Product
Table 71. Creatv Microtech Revenue in Circulating Tumor Cells (CTC) Business (2018-2023) & (US$ Million)
Table 72. Creatv Microtech Recent Development
Table 73. Ikonisys Company Detail
Table 74. Ikonisys Business Overview
Table 75. Ikonisys Circulating Tumor Cells (CTC) Product
Table 76. Ikonisys Revenue in Circulating Tumor Cells (CTC) Business (2018-2023) & (US$ Million)
Table 77. Ikonisys Recent Development
Table 78. IV Diagnostics Company Detail
Table 79. IV Diagnostics Business Overview
Table 80. IV Diagnostics Circulating Tumor Cells (CTC) Product
Table 81. IV Diagnostics Revenue in Circulating Tumor Cells (CTC) Business (2018-2023) & (US$ Million)
Table 82. IV Diagnostics Recent Development
Table 83. Miltenyi Biotech Company Detail
Table 84. Miltenyi Biotech Business Overview
Table 85. Miltenyi Biotech Circulating Tumor Cells (CTC) Product
Table 86. Miltenyi Biotech Revenue in Circulating Tumor Cells (CTC) Business (2018-2023) & (US$ Million)
Table 87. Miltenyi Biotech Recent Development
Table 88. Nanostring Technologies Company Detail
Table 89. Nanostring Technologies Business Overview
Table 90. Nanostring Technologies Circulating Tumor Cells (CTC) Product
Table 91. Nanostring Technologies Revenue in Circulating Tumor Cells (CTC) Business (2018-2023) & (US$ Million)
Table 92. Nanostring Technologies Recent Development
Table 93. Rarecells Diagnostics Company Detail
Table 94. Rarecells Diagnostics Business Overview
Table 95. Rarecells Diagnostics Circulating Tumor Cells (CTC) Product
Table 96. Rarecells Diagnostics Revenue in Circulating Tumor Cells (CTC) Business (2018-2023) & (US$ Million)
Table 97. Rarecells Diagnostics Recent Development
Table 98. Vitatex Company Detail
Table 99. Vitatex Business Overview
Table 100. Vitatex Circulating Tumor Cells (CTC) Product
Table 101. Vitatex Revenue in Circulating Tumor Cells (CTC) Business (2018-2023) & (US$ Million)
Table 102. Vitatex Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Circulating Tumor Cells (CTC) Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Circulating Tumor Cells (CTC) Market Share by Type: 2022 VS 2033
Figure 3. Ex-Vivo Positive Selection Features
Figure 4. In-Vivo Positive Selection Features
Figure 5. Negative Selection Features
Figure 6. Microchips & Single Spiral Micro Channel Features
Figure 7. Global Circulating Tumor Cells (CTC) Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 8. Global Circulating Tumor Cells (CTC) Market Share by Application: 2022 VS 2033
Figure 9. Tumorigenesis Research Case Studies
Figure 10. Emt Biomarkers Development Case Studies
Figure 11. Cancer Stem Cell Research Case Studies
Figure 12. Others Case Studies
Figure 13. Circulating Tumor Cells (CTC) Report Years Considered
Figure 14. Global Circulating Tumor Cells (CTC) Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 15. Global Circulating Tumor Cells (CTC) Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 16. Global Circulating Tumor Cells (CTC) Market Share by Region: 2022 VS 2033
Figure 17. Global Circulating Tumor Cells (CTC) Market Share by Players in 2022
Figure 18. Global Top Circulating Tumor Cells (CTC) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Circulating Tumor Cells (CTC) as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Circulating Tumor Cells (CTC) Revenue in 2022
Figure 20. North America Circulating Tumor Cells (CTC) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. North America Circulating Tumor Cells (CTC) Market Share by Country (2018-2033)
Figure 22. United States Circulating Tumor Cells (CTC) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada Circulating Tumor Cells (CTC) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Circulating Tumor Cells (CTC) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Circulating Tumor Cells (CTC) Market Share by Country (2018-2033)
Figure 26. Germany Circulating Tumor Cells (CTC) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. France Circulating Tumor Cells (CTC) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. U.K. Circulating Tumor Cells (CTC) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Italy Circulating Tumor Cells (CTC) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Russia Circulating Tumor Cells (CTC) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Nordic Countries Circulating Tumor Cells (CTC) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Circulating Tumor Cells (CTC) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific Circulating Tumor Cells (CTC) Market Share by Region (2018-2033)
Figure 34. China Circulating Tumor Cells (CTC) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Japan Circulating Tumor Cells (CTC) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. South Korea Circulating Tumor Cells (CTC) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Southeast Asia Circulating Tumor Cells (CTC) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. India Circulating Tumor Cells (CTC) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Australia Circulating Tumor Cells (CTC) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Circulating Tumor Cells (CTC) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America Circulating Tumor Cells (CTC) Market Share by Country (2018-2033)
Figure 42. Mexico Circulating Tumor Cells (CTC) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Brazil Circulating Tumor Cells (CTC) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Circulating Tumor Cells (CTC) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa Circulating Tumor Cells (CTC) Market Share by Country (2018-2033)
Figure 46. Turkey Circulating Tumor Cells (CTC) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Saudi Arabia Circulating Tumor Cells (CTC) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. AdnaGen Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2018-2023)
Figure 49. Apocell Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2018-2023)
Figure 50. Biocep Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2018-2023)
Figure 51. Canopus Bioscience Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2018-2023)
Figure 52. Creatv Microtech Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2018-2023)
Figure 53. Ikonisys Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2018-2023)
Figure 54. IV Diagnostics Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2018-2023)
Figure 55. Miltenyi Biotech Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2018-2023)
Figure 56. Nanostring Technologies Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2018-2023)
Figure 57. Rarecells Diagnostics Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2018-2023)
Figure 58. Vitatex Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2018-2023)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed